Carregant...
Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm
Acute myeloid leukemia is a genetically heterogeneous hematologic malignancy; approximately 20% of AML harbors a mutation in the isocitrate dehydrogenase (IDH) genes, IDH1 or IDH2. These recurrent mutations in key metabolic enzymes lead to the production of the oncometabolite 2-hydroxyglutarate, whi...
Guardat en:
| Publicat a: | Blood Cancer J |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8175383/ https://ncbi.nlm.nih.gov/pubmed/34083508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00497-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|